Evidence of vascular endothelial damage in Crimean-Congo hemorrhagic fever

Hürrem Bodur1, Esragül Akinci, Pinar Ongürü

  • 1Department of Infectious Diseases and Clinical Microbiology, Ankara Numune Education and Research Hospital, Samanpazari, Ankara, Turkey. hurrembodur@gmail.com

Insights

This study reveals that Crimean-Congo hemorrhagic fever (CCHF) impacts vascular endothelial damage indirectly, with specific biomarkers like soluble vascular cell adhesion molecule-1 (sVCAM-1) and vascular endothelial growth factor (VEGF) showing potential in predicting mortality.

Area of Science:

  • * Virology and Immunology
  • * Pathophysiology of Infectious Diseases
  • * Clinical Biomarker Research

Background:

  • * Endothelial infection plays a key role in Crimean-Congo hemorrhagic fever (CCHF) pathogenesis.
  • * Investigating the mechanisms of vascular endothelial damage in CCHF is crucial for understanding disease progression.

Purpose of the Study:

  • * To investigate the causes of vascular endothelial damage in patients diagnosed with CCHF.
  • * To identify potential biomarkers associated with disease severity and mortality in CCHF.

Main Methods:

  • * A prospective case-controlled study involving 75 laboratory-confirmed CCHF patients and 88 healthy controls.
  • * Serum levels of soluble cell adhesion molecules (sICAM-1, sVCAM-1, sE-selectin, sP-selectin, sL-selectin), vascular endothelial growth factor (VEGF), and macrophage migration inhibitory factor (MIF) were measured using ELISA.

Main Results:

  • * Significantly higher serum levels of sVCAM-1, sL-selectin, and MIF were observed in CCHF patients compared to controls.
  • * Lower serum levels of sICAM-1, sP-selectin, sE-selectin, and VEGF were found in CCHF patients.
  • * sVCAM-1 and VEGF levels differentiated between severe and non-severe cases, and survivors versus non-survivors, with specific cut-offs identified for mortality prediction.

Conclusions:

  • * Endothelial activation appears to influence the course of CCHF, suggesting indirect vascular endothelial damage.
  • * Further research is warranted to establish definitive conclusions regarding the role of endothelial markers in CCHF.
Abstract